Greenleaf Envirotech approves Rs 2 crore infusion in subsidiary
Greenleaf Envirotech Limited's Board approved a Rs 2 crore capital infusion into its wholly owned subsidiary, Greenleaf Eco Infra Private Limited (GEIPL). The investment, to be made via a Rights Issue subscription before September 30, 2026, aims to support GEIPL's operational needs, working capital, and expansion in the environmental infrastructure sector.
*this image is generated using AI for illustrative purposes only.
Greenleaf Envirotech Limited has approved a capital infusion of up to Rs 2 crore in its wholly owned subsidiary, Greenleaf Eco Infra Private Limited (GEIPL). The investment, approved by the Board of Directors on May 28, 2026, will be executed in one or more tranches by subscribing to the Rights Issue of GEIPL before September 30, 2026. The funds are intended to meet the subsidiary's operational requirements, working capital needs, capital expenditure, and business expansion plans.
The Board meeting, which commenced at 3.00 P.M. and concluded at 8.25 P.M., sanctioned the proposal under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The transaction involves a related party, as GEIPL is a wholly owned subsidiary, but it will be conducted at arm's length. The Promoter and Promoter Group hold no interest in the target entity other than their shareholding in the parent company.
Details of the Capital Infusion
The following table outlines the key details of the capital infusion and the target entity:
| S. No. | Particulars | Details |
|---|---|---|
| 1 | Name of the target entity | Greenleaf Eco Infra Private Limited ("GEIPL"), a wholly owned subsidiary of the Company. GEIPL is incorporated July 8, 2025 and the turnover of GEIPL for the financial year ended March 31, 2026, is Nil. |
| 2 | Related party transaction | The Target Entity is a Wholly Owned Subsidiary of the Company and hence a related party. The transaction is at arm's length. Promoter/Promoter Group have no interest other than their shareholding in the Company. |
| 3 | Industry | Environmental Infrastructure |
| 4 | Objects and impact | Investment in the Wholly Owned Subsidiary for meeting its operational requirements, working capital needs, capital expenditure and business expansion plans. |
| 5 | Governmental approvals | Not applicable |
| 6 | Time period for completion | By September 30, 2026. |
| 7 | Nature of consideration | Cash consideration |
| 8 | Cost of acquisition | Up to Rs. 2,00,00,000/- (Rupees Two Crore only), in one or more tranches before September 30, 2026. Pre Acquisition Shareholding: 100%. Post Acquisition Shareholding: 100%. |
| 9 | Shareholding acquired | The Company will subscribe to the Rights Issue of its Wholly Owned Subsidiary. Post subscription, the GEIPL will continue to remain a Wholly Owned Subsidiary of the Company. |
Background of GEIPL
GEIPL is presently engaged in the business of establishing, operating, and maintaining Common Effluent Treatment Plants (CETPs) for the treatment, recycling, reuse, and disposal of industrial effluents and wastewater in accordance with applicable environmental laws and regulations. The entity also undertakes allied activities relating to pipeline infrastructure, sludge handling and management, resource recovery, and other environmental infrastructure associated with CETP operations. Incorporated on July 8, 2025, GEIPL reported a turnover of Nil for FY 2025-26 and operates within India.
Historical Stock Returns for Greenleaf Envirotech
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.36% | -1.90% | -2.32% | -58.87% | -47.63% | -47.63% |
What specific expansion projects or new contracts does Greenleaf Envirotech plan to pursue with this capital infusion?
How will the company measure the success and ROI of this investment given GEIPL's current nil turnover?
Are there plans to secure additional funding beyond this Rs 2 crore to support long-term growth?
15
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
